Corporate Governance

Annual Generel Meeting May 7 2019

General Meetings

In accordance with the Companies Act, the Annual General Meeting is the Company’s highest decision-making body.

At the Annual General Meeting, shareholders exercise their voting rights in key matters, such as the determination of income and balance sheets, disposition of the Company’s results, discharge of the Board of Directors and the CEO, election of board members and auditors, and decisions on remuneration to the Board and auditors. The shareholder who is entered in the share register and has notified his/her participation in time to the AGM is entitled to participate and vote for his/her shares. Shareholders may also be represented by representatives at the general meeting. One share gives the right to one vote at the Annual General Meeting. There are no limits as to how many votes each shareholder may submit at the Annual General Meeting. In addition to the Annual General Meeting, an Extraordinary General Meeting may be held.

In accordance with the articles of association, notice to the Annual General Meeting is to be made by advertising in Post- och Inrikes Tidningar and by making the notice available on the Company’s website. At the same time as a call is made, the Company shall announce that a notice has been made by announcement in Svenska Dagbladet. Notice of Annual General Meeting and convening an Extraordinary General Meeting, in which an amendment to the Articles of Association will be considered, shall be issued no earlier than six weeks and no later than four weeks before the meeting. Notice of extraordinary general meeting shall be issued no earlier than six weeks and no later than two weeks priorthe meeting.

Share

Facebook
Twitter
LinkedIn

Contact us

Address: Grev Turegatan 11 C, 114 46 Stockholm, Sweden

Phone: +46 8 679 72 10

E-mail: info@pledpharma.com